ClinicalTrials.gg
RecruitingNCT05321459PRECOMUpdated Dec 23, 2025

Predictive Outcome in Comatose Patients

An observational study in Coma, Heart Arrest and Cardiopulmonary Resuscitation, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 7 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-23.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

From the registry’s dates

  • Started Nov 2023; still recruiting 2 years 11 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

Evaluating the prognosis of comatose patients after cardiac arrest (CA) in the intensive care unit (ICU) remains challenging. It requires a multimodal approach combining standardized clinical examination, serum biomarkers, imaging and classically electrophysiological examinations, (among them auditive evoked potentials or AEP) but none has a sufficient sensitivity/specificity. In a preliminary study, the investigators developed an algorithm from the signal collected with AEP, and generated a probability map to visually classify the participants after the algorithm processing. Participants could be classified either with a good neurological prognosis or with bad neurological prognosis or death.

The investigators hypothesize that the "PRECOM" tool, applied blindly to a large prospective multicenter cohort of patients admitted to intensive care for coma in the aftermath of CA will predict neurological prognosis at 3 months with high sensitivity and specificity.

Read the detailed description

Evaluating the prognosis of comatose participants after cardiac arrest (CA) in the intensive care unit remains challenging. It requires a multimodal approach combining standardized clinical examination, serum biomarkers, imaging and classically electrophysiological examinations: 1 / the electroencephalogram, bad prognosis assessed when the electroencephalogram (EEG) is discontinuous, areactive, monotone,…), 2 / somesthetic evoked potentials, the absence of the N20 cortical wave has a specificity of poor prognosis of 68-100% and 3 / auditory evoked potentials (AEP), the presence of mismatchnegativity (MMN) would be of good prognosis with a specificity up to 90% but rarely performed in current practice. Routinely, these examinations are sometimes difficult to interpret in sedated participants, in an intensive care unit environment that generates numerous artefacts. Above all, all these techniques require the presence of a neurophysiology unit, with few experts available.

In a preliminary study, in collaboration with the applied mathematics laboratory of the ENS (Ecole Normale Supérieure), an algorithm was developed from the signal extracted from AEP. A probability map was generated with a software allowing to visually classify the participants after processing signal by the algorithm in a cluster of points with a high specificity into "good neurological prognosis" and "bad neurological prognosis". Neither artifacts or sedation prevented data analysis.

The investigators hypothesize that the "PRECOM" tool, applied blindly to a large prospective multicenter cohort of participants admitted to intensive care for coma in the aftermath of a caridiac arrest will predict the neurological prognosis of participants with high sensitivity and specificity. This tool, carried out during the first week of the coma, will be compared to a standardized procedure used routinely by the participating resuscitators.

02

Conditions studied

  • Coma
  • Heart Arrest
  • Cardiopulmonary Resuscitation

Browse trials for

Keywords

  • Post cardiac arrest for comatose patients
  • Electroencephalography
  • Somatosensory evoked potentials
  • Auditory evoked potentials
  • Prognosis
  • Algorithms
  • Classification
03

In context

Coma

138 studies on the registry are indexed under Coma; 35 are open to participants now.

This study's planned enrollment of 100 is close to the median of 100 across 58 observational studies indexed under Coma.

Browse Coma studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,592 studies on the registry; 1,033 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Adult patients admitted to intensive care following a cardica arrest.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age above18 years old
  • Patient affiliated to a French Heath Care Insurance
  • Admitted in the intensive care unit (ICU) for coma post extra- or intra-hospital cardiac arrest (CA) with shockable or non-shockable rhythm
  • Persistent coma on day 3 after post CA, defined by the inability to respond to a verbal command in an appropriate manner (motor Glasgow components ≤ 3) and at the time of neurophysiological recordings (D3-D7 ± week -end).

Exclusion criteria

Exclusion Criteria:

  • Decision to limit resuscitation therapies taken by the resuscitation team
  • Inability to perform the auditory evoked potentials (AEP) (deafness, skin lesion or any condition preventing to record AEP).
  • Opposition by the trusted person or by the patient once he/she wakes up
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Comatose patients in intensive care unit

    Patient admitted in the intensive care unit (ICU) for post cardiac arrest (CA) coma, persistent for at least 3 days after CA.

    Other: Neurological prognosis

Interventions

  • OtherNeurological prognosis

    In usual practice, in intensive care unit, evaluating the neurological prognosis of comatose patients after cardiac arrest requires a multimodal approach combining standardized clinical examination, serum biomarkers, imaging and classically electrophysiological examinations (among them auditive evoked potentials or AEP). An algorithm (PRECOM tool) which has been previously developed from the signal extracted from AEP allows to visually classify the patients after processing signal by the algorithm in a cluster of points with a high specificity into "good neurological prognosis" and "bad neurological prognosis". The AEP signals recorded in the 1st and 2nd week of patient inclusion are to be collected by the neurophysiologist. At the end of the patient's participation in the study, these data will be encrypted, anonymized and transmitted to the mathematician to be processed by the PRECOM tool.

06

What researchers measure

Primary outcomes

  1. Awakening within 3 months

    Awakening is defined as normal motor activity in response to the 3 instructions for the motor component M of the FOUR score (show your thumb, make the V for victory and show your fist; M = 4). This criterion will be collected by the doctor in charge of the patient at the time of the assessment and will be dated.

    Time frame: within 3 months ± 2 weeks after inclusion

Secondary outcomes

  1. CPC score within 3 months

    CPC (Cerebral Performance Category) score is performed wether patient is still hospitalized or returned home. It is performed by phone call if patient returned home. Range of values rates neurological status after cardiac arrest on a scale of 1 to 5 (1 for good cerebral performance up to 5 for brain death).

    Time frame: 3 months ± 2 weeks after inclusion

  2. mRS score within 3 months

    mRS (Modified Rankin Scale) scores is performed wether patient is still hospitalized or returned home. It is performed by phone call if patient returned home. mRS (modified Rankin Scale) scale measures degree of disability/dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. Score can be between 0 (no symptoms at all) and 5 (major disability : bedridden, incontinent and requiring constant nursing care and attention).

    Time frame: 3 months ± 2 weeks after inclusion

  3. FOUR score within 3 months

    FOUR (Full Outline of UnResponsiveness) score is performed only if patient is still hospitalized (being awake or not). FOUR score is a grading scale for assessing the level of consciousness performed on patients with severe neurologic impairment..It addresses four domains of neurological functioning: Eye response; Motor response ; Brainstem score and Respiratory score. Score is ranging from 0 to 16 where the lower the score, the greater the coma gravity.

    Time frame: 3 months ± 2 weeks after inclusion

  4. GOSE score within 3 months

    GOSE (Extended Glasgow Outcome Scale) score is performed wether patient is still hospitalized or returned home. GOSE score classifies global outcomes in traumatic brain injury survivors. It rates patient status into one of eight categories ranging from 8 (Upper good recovery) to 1 (Dead).

    Time frame: 3 months ± 2 weeks after inclusion

  5. CPC score within 6 months

    CPC (Cerebral Performance Category) score is performed wether patient is still hospitalized or returned home. It is performed by phone call if patient returned home. Range of values rates neurological status after cardiac arrest on a scale of 1 to 5 (1 for good cerebral performance up to 5 for brain death).

    Time frame: 6 months ± 2 weeks after inclusion

  6. mRS score within 6 months

    mRS (Modified Rankin Scale) scores is performed wether patient is still hospitalized or returned home. It is performed by phone call if patient returned home. mRS (modified Rankin Scale) scale measures degree of disability/dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. Score can be between 0 (no symptoms at all) and 5 (major disability : bedridden, incontinent and requiring constant nursing care and attention).

    Time frame: within 6 months ± 2 weeks after inclusion

  7. GOSE score within 6 months

    GOSE (Extended Glasgow Outcome Scale) score is performed wether patient is still hospitalized or returned home. GOSE score classifies global outcomes in traumatic brain injury survivors. It rates patient status into one of eight categories ranging from 8 (Upper good recovery) to 1 (Dead).

    Time frame: within 6 months ± 2 weeks after inclusion

  8. Awakening within 6 months ± 2 weeks

    Awakening is defined as normal motor activity in response to the 3 instructions for the motor component M of the FOUR score (show your thumb, make the V for victory and show your fist; M = 4). This criterion will be collected by the doctor in charge of the patient at the time of the assessment and will be dated. The measurement takes place only if patient is still hospitalized.

    Time frame: within 6 months ± 2 weeks after inclusion

  9. CRS-R score within 6 months

    CRS-R (Coma Recovery Scale - Revised) is a standardized neurobehavioral assessment measure designed for use in patients with disorders of consciousness. The scale is intented to be used to establish diagnosis, monitor behavioral recovery and predict outcome. It is performed only if patient is still hospitalized. The total score ranges between 0 (worst) and 23 (best).

    Time frame: within 6 months ± 2 weeks after inclusion

  10. PRECOM tool - first week of coma

    Comparison of the ability of the PRECOM tool using clinical and electrophysiological data at inclusion (the first week of coma), to classify patients with good prognosis, poor prognosis and indeterminate prognosis with respect to this same categorization using the usual evaluation criteria performed routinely by participating resuscitations (clinical examination and EEG for all and evoked potentials in addition for some).

    Time frame: Inclusion visit (3 to 7 days after cardiac arrest +/- 2 days if week-end)

  11. PRECOM tool - second week of coma

    Comparison of the ability of the PRECOM tool using clinical and electrophysiological data the second week of coma, to classify patients with good prognosis, poor prognosis and indeterminate prognosis with respect to this same categorization using the usual evaluation criteria performed routinely by participating resuscitations (clinical examination and EEG for all and evoked potentials in addition for some).

    Time frame: One week visit (one week after inclusion visit +/- 2 days)

  12. PRECOM tool - first and second week of coma

    Comparison of the ability of the PRECOM tool using combinaison of clinical and electrophysiological data collected both at inclusion and one week later (the first two weeks of coma), to classify patients with good prognosis, poor prognosis and indeterminate prognosis with respect to this same categorization using the usual evaluation criteria performed routinely by participating resuscitations (clinical examination and EEG for all and evoked potentials in addition for some).

    Time frame: Inclusion and one week visits

  13. Awakening - second week of coma

    Awakening is defined as normal motor activity in response to the 3 instructions for the motor component M of the FOUR score (show your thumb, make the V for victory and show your fist; M = 4). This criterion will be collected by the doctor in charge of the patient at the time of the assessment and will be dated.

    Time frame: One week visit (one week after inclusion visit +/- 2 days)

  14. NSE blood marker

    Comparison of the ability to predict awakening with the PRECOM tool using the NSE blood marker (neuron- spécific enolase) collected 3 days after cardiac arrest between the patients awakened from the coma and those who are not.

    Time frame: 3 days post cardiac arrest

  15. Glial blood markor

    Comparison of the ability to predict awakening with the PRECOM tool using the Glial Fibrillary Acidic Protein (GFAP) collected at the inclusion visit between the patients awakened from the coma and those who are not.

    Time frame: Inclusion visit (3 to 7 days after cardiac arrest +/- 2 days if week-end)

  16. Neuronal blood markor

    Comparison of the ability to predict awakening with the PRECOM tool using the Neurofilament blood marker collected at the inclusion visit between the patients awakened from the coma and those who are not.

    Time frame: Inclusion visit (3 to 7 days after cardiac arrest +/- 2 days if week-end)

  17. Inflammatory blood markor

    Comparison of the ability to predict awakening with the PRECOM tool using the inflammatory blood markers : Kynurenine and Tryptophan; collected at the inclusion visit between the patients awakened from the coma and those who are not.

    Time frame: Inclusion visit (3 to 7 days after cardiac arrest +/- 2 days if week-end)

07

Study locations

6 of 7 sites recruiting
  • APHP Avicenne Hospital - Réanimation médico-chirurgicale
    Bobigny, 93000, France
    Recruiting
    • Johanna OZIEL, Ph · Contactjohanna.oziel@aphp.fr · +33 1 48 95 52 41
    • Johanna OZIEL, Ph · Principal investigator
  • APHP Lariboisière Hospital, Clinical Physiology Department
    Paris, 75010, France
    Active, not recruiting

    Not enrolling at this site.

  • APHP Laribosière Hospital - Service de Réanimation Médical et Toxicologique
    Paris, 75010, France
    Recruiting
    • Bruno MEGARBANE, MD, PhD · Contactbruno.megarbane@aphp.fr · +33 (0)1 49 95 64 91
    • Bruno MEGARBANE, Md, PhD · Principal investigator
  • APHP Cochin Hospital - médecine intensive-réanimation
    Paris, 75014, France
    Recruiting
    • Sarah BENGHANEM, Ph · Contactsarah.benghanem@aphp.fr · +33 1 58 41 25 33
    • Sarah BENGHANEM, Ph · Principal investigator
  • APHP HEGP hospital - Réanimation médicale
    Paris, 75015, France
    Recruiting
  • APHP Bichat Hospital -Médecine intensive - réanimation infectieuse
    Paris, 75018, France
    Recruiting
    • Marc DOMAN, Ph · Contactmarc.doman@aphp.fr · +33 1 40 25 79 24
    • Marc DOMAN, Ph · Principal investigator
  • Delafontaine Hospital - médecine intensive-réanimation
    Saint-Denis, 93200, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05321459
Collaborators
Ecole Normale Supérieure de Paris
Responsible party
Sponsor
First posted
Apr 11, 2022
Start date
Nov 15, 2023
Primary completion
Mar 1, 2028 (estimated)
Completion
May 29, 2028 (estimated)
Last update
Dec 23, 2025

Study contacts

Nathalie KUBIS, Md, PhD
Contact
nathalie.kubis@aphp.fr
+33(0)149958324
Romain SONNEVILLE, Md, PhD
Contact
romain.sonneville@aphp.fr
+33(0)140256139
Nathalie KUBIS, Md,PhD
study director · APHP Lariboisière Hospital, Clinical Physiology Department

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion